Published in J Pharmacol Exp Ther on November 01, 2002
The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci (2008) 3.54
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res (2009) 2.61
Dynorphin, stress, and depression. Brain Res (2009) 2.45
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) (2010) 2.19
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A (2009) 1.88
30 years of dynorphins--new insights on their functions in neuropsychiatric diseases. Pharmacol Ther (2009) 1.50
Opioid receptors: distinct roles in mood disorders. Trends Neurosci (2012) 1.31
Contributions of serotonin in addiction vulnerability. Neuropharmacology (2011) 1.12
Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults. J Clin Psychiatry (2014) 1.08
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci (2012) 1.04
The kappa opioid receptor: from addiction to depression, and back. Front Psychiatry (2014) 0.94
Effects of opioids, cannabinoids, and vanilloids on body temperature. Front Biosci (Schol Ed) (2011) 0.90
Voluntary wheel running produces resistance to inescapable stress-induced potentiation of morphine conditioned place preference. Behav Brain Res (2011) 0.85
The effects of a single exposure to uncontrollable stress on the subsequent conditioned place preference responses to oxycodone, cocaine, and ethanol in rats. Psychopharmacology (Berl) (2007) 0.84
Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G protein-coupled receptors and ion channels. Front Integr Neurosci (2013) 0.82
Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus. Neuroscience (2013) 0.81
Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats. Psychoneuroendocrinology (2011) 0.81
Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse. Adv Pharmacol (2014) 0.81
Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling. Nucleic Acids Res (2014) 0.77
Effect of fentanyl on 5-HT efflux involves both opioid and 5-HT1A receptors. Br J Pharmacol (2003) 0.77
The effects of a single session of inescapable tailshock on the subsequent locomotor response to brief footshock and cocaine administration in rats. Psychopharmacology (Berl) (2007) 0.77
Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology (Berl) (2013) 0.77
Dopamine is differentially involved in the locomotor hyperactivity produced by manipulations of opioid, GABA and glutamate receptors in the median raphe nucleus. Behav Brain Res (2013) 0.76
Modulation of serotonin transporter function by kappa-opioid receptor ligands. Neuropharmacology (2016) 0.75
Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan. Clin Psychopharmacol Neurosci (2017) 0.75
Influence of inhibitory and excitatory inputs on serotonin efflux differs in the dorsal and median raphe nuclei. Brain Res (2003) 0.97
GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system. J Pharmacol Exp Ther (2002) 0.95
mu-Opioids disinhibit and kappa-opioids inhibit serotonin efflux in the dorsal raphe nucleus. Brain Res (2005) 0.90
Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.88
Involvement of 5-HT2A receptors in the serotonin (5-HT) syndrome caused by excessive 5-HT efflux in rat brain. Basic Clin Pharmacol Toxicol (2010) 0.82
Changes in gamma-aminobutyric acid tone and extracellular serotonin in the dorsal raphe nucleus over the rat estrous cycle. Neuroendocrinology (2004) 0.81
Effect of fentanyl on 5-HT efflux involves both opioid and 5-HT1A receptors. Br J Pharmacol (2003) 0.77